Congressional Budget Office Cost Estimate: H.R. 5533: Biodefense and Pandemic Vaccine and Drug Development Act of 2006 [open pdf - 17KB]
"H.R. 5533 would create an office at the Department of Health and Human Services (HHS) called the Biomedical Advanced Research and Development Authority (BARDA). BARDA would oversee advanced research and development of products to defend against bioterrorism and pandemic influenza. The bill also would establish the National Biodefense Science Board, an advisory group that would provide scientific guidance to HHS on issues involving chemical, biological, radiological, and nuclear agents. Additionally, the bill would require HHS to establish a team of experts at the Food and Drug Administration (FDA) to provide technical assistance to drug manufacturers when shortages of certain vaccines and drugs occur. H.R. 5533 also would clarify that Project BioShield, a program that provides incentives to companies to manufacture vaccines and drugs, covers certain products - so-called qualified and security countermeasures-that address public health threats caused by acts of terrorism. The bill would authorize the appropriation of $160 million for each of fiscal years 2007 and 2008 for activities related to the operation of BARDA. The bill also would authorize the appropriation of $1 million for each of fiscal years 2007 and 2008 for the National Biodefense Science Board. CBO estimates that $1 million a year would be necessary for FDA to implement activities outlined in the bill."
Congressional Budget Office: http://cbo.gov